Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

Best-of-Day Video Highlights

Highlights from the recent SNO Meeting and a complete list of abstracts

Read Full Story

Call for Abstracts - SNO Pediatric Neuro-Oncology Basic and Translational Research Conference

Submission Deadline - Friday, January 20, 2017

Read Full Story

Career Lounge at SNO

Thank you to all employers and applicants

Read Full Story
View All News

February
19

CNIO Frontiers Meeting - Primary and Secondary Brain Tumors

Read Full Story

February
24

10th Annual International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery

Read Full Story

March
02

Twenty-Third Annual Blood-Brain Barrier Consortium Meeting

Read Full Story

2015 SNO Award Recipients

 

SNO CONGRATULATES THIS YEAR'S OUTSTANDING LIST OF AWARD RECIPIENTS WHO WERE RECOGNIZED AT THE 20TH ANNUAL MEETING AND EDUCATION DAY HELD NOVEMBER 19-22, 2015, IN SAN ANTONIO, TEXAS.

 

VICTOR LEVIN AWARD & LECTURE
Mitchel Berger, MD "Team Neuro-Oncology: The Sum is More Important than its Parts"

BergerWeb.jpg

Victor Levin (L) presented the award to Mitchel Berger (R)

 

LIFETIME ACHIEVEMENT AWARD
W.K. Alfred Yung, MD

Yung3web.jpg

W.K. Alfred Yung (L) received the award from David Reardon (R)

 

PUBLIC SERVICE AWARD
Jan Esenewein

Jan_Awardweb.jpg

Jan Esenwein (L) received the award from Chas Haynes (R)

 

ABSTRACT AWARDS

PEDIATRIC BASIC RESEARCH AWARD
PTPS-15: ATRX loss promotes tumor growth and impairs non-homologous end joining DNA repair in glioma
Koschmann C, Calinescu A, Nunez F, Mckay A, Salom JF, Thomas D, Mulpuri L, Kamran N, Mendez F, Dzaman M, Krasinkiewicz J, Lemons R, Zhao L, Appelman H, Ferguson D, Gorbunova V, Meeker A, Jones C, Lowenstein PR, Castro MG

Koschmann_Carlweb.jpg

 

ADULT TRANSLATIONAL RESEARCH AWARD
ATPS-37: Therapeutic vulnerabilities and resistance mechanisms for the precision medicine of glioblastoma
Lasorella A, Iavarone A

Iavorone_Aweb.jpg

 

ADULT BASIC RESEARCH AWARD CO-RECIPIENT
STEM-22: Large-scale single-cell RNA-seq reveals a developmental cellular hierarchy in human oligodendroglioma
Venteicher A, Tirosh I, Hebert C, Escalante L, Nahed B, Cahill D, Curry W, Martuza R, Bernstein B, Louis D, Regev A, Suva M

Ventreicher_Andrewweb.jpg

 

ADULT BASIC RESEARCH AWARD CO-RECIPIENT
IMPS-29: Refuting brain immune privilege: longitudinal multiphoton imaging through skull windows reveals the immune surveillance of brain metastases and its regulation by fractalkine
Nwajei F, Beceren-Braun F, Shanmugasundaram M, Zal A, Wu WI, Heimberger A, Zal T

Nwajei_Felixweb.jpg

 

PEDIATRIC TRANSLATIONAL RESEARCH AWARD
TMOD-01: BCOR is a novel tumor suppressor gene in SHH-driven medulloblastoma
Batora NV, Giese M, Sieber L, Pfister SM, Bardwell V, Kawauchi D, Northcott PA

Batora

 

CLINICAL RESEARCH ADULT AWARD CO-RECIPIENT
IMCT-08: ReACT: Long-term survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma
Reardon DA, Desjardins A, Schuster J, Tran DD, Fink KL, Nabors LB, Li G, Bota DA, Lukas RV, Ashby LS, Duic JP, Mrugala MM, Werner A, Vitale L, He Y, Green J, Yellin MJ, Turner CD, Davis TA, Sampson JH

Reardon_Davidweb.jpg

 

CLINICAL RESEARCH ADULT AWARD CO-RECIPIENT
ATCT-12: Results of NRG Oncology/RTOG 9813- a phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA)
Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas C, Aldape KD, Bell E, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas Prado M, Robins HI, Belanger K, Schultz CJ, Chakravarti A, Mehta M

Chang_Susanweb.jpg

 

YOUNG INVESTIGATOR BASIC/TRANSLATIONAL RESEARCH AWARD
CSIG-04: Lipid metabolism reprogramming in glioblastoma and serving as promising target
Guo D, Cheng C, Geng F, Ru P, Wu X, Hu P, Cheng X, Kaur B, Chakravarti A, Yunhua Guo J

Guo_Deliangweb.jpg

 

YOUNG INVESTIGATOR CLINICAL RESEARCH AWARD
EPID-31: ATRX and TERT assays provide non-redundant information in adult glioma patients: incorporating telomere markers into neuropathology practice
Walsh K, Pekmezci M, Decker P, Hansen H, Sicotte H, Rice T, Kollmeyer T, McCoy L, Sarkar G, Perry A, Giannini C, Tihan T, Berger M, Molinaro A, Wiemels J, Eckel-Passow J, Lachance D, Wiencke J, Jenkins R, Wrensch M

Walsh_Kyleweb.jpg

 

QUALITY OF LIFE RESEARCH AWARD
QOL-22: The impact of pregnancy on glioma patients
Stone J, Graber J, Kaley T, DeAngelis L

Stone_Jacquelineweb.jpg

 

EPIDEMIOLOGY RESEARCH AWARD
EPID-25: Germline polymorphisms in MGMT increase ability to model temozolomide (TMZ)-related myelotoxicity risk in patients with glioblastoma (GBM) treated on NRG Oncology/RTOG 0825
Scheurer M, Zhou R, Gilbert M, Bondy M, Sulman E, Yuan Y, Liu Y, Vera-Bolanos E, Wendland M, Brachman D, Steiber V, Komaki R, Flickinger J, Kenyon L, Robins I, Hunter G, Crocker I, Chao S, Stella P, Pugh S , Armstrong T

Scheurer_Mweb.jpg

 

TOP ORAL POSTER PRESENTATIONS:

The following abstracts were chosen as the top presentation in their respective evening Oral Poster Session. Award receipients receive a commemorative certificate and complimentary registration to the 2016 SNO meeting in Scottsdale, Arizona.

 

RTRB-14: Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus
Palmer J, Mehta M, Williams N, Dicker A, Werner-Wasik M, Shi W

ATNT-01: ABT-414 mono- or combination therapy with temozolomide (TMZ) rechallenge in patients with recurrent glioblastoma (GBM) and amplified epidermal growth factor receptor (EGFR): A phase I study
Gan Hui K., Kumthekar Priya, Lassman Andrew B., Merrell R, van den Bent M, Papadopoulos KP, Scott AM, Gomez E, Fischer J, Mandich H, Xiong H, Lee Ho, Munasinghe W, Roberts-Rapp L, Ansell P, Holen K, Lai R, Reardon DA

DDEL-17: CSF pharmacokinetics and pharmacodynamics in brain cancer patients on high-dose erlotinib
Pingle S, Langley E, Juarez T, Saria M, Meyer G, Kim P, Kesari S

ATPS-55: Influence of MAPK and PI3K pathway mutations on response to targeted inhibitors
McNeill RS, Canoutas DA, Schmid RS, Bash RE, Constance BB, Azam SH, Reuther RA, Johnson GL, Miller CR

ANGI-04: Olig2 regulates Wnt7b expression and vasculature characteristics in glioma
Griveau A, Shelton S, Tien A, Seano G, Yuen T, Sabo J, Lau J, Jahangiri A, Huillard E, Phillips J, Persson A, Oldham M, Weiss W, Aghi M, Stiles C, Mehta S, Batchelor T, Jain R, Rowitch D

IMPS-01: Gr-1+/CD11b+ myeloid cells are required for natural killer cell-mediated eradication of galectin-1-deficient glioma
Baker G, Chockley P, Zamler D, Castro M, Lowenstein P

IMPS-45: IDH mutant gliomas escape natural killer cell immune surveillance through downregulation of NKG2D ligands
Zhang X, Rao A, Deibert C, Sette P, Kim J, Lotze M, Grandi P, Amankulor N

EPID-05: Epidemiology of brain and central nervous system tumors in adolescents and young adults in the United States
Ostrom Q, Kruchko C, Barnholtz-Sloan J

GENO-07: A mechanism of mutant TERT promoter activation shared across cancer types
Bell R, Rube HT, Kreig A, Mancini A, Fouse S, Nagarajan R, Choi S, Hong C, He D, Pekmezci M, Wiencke J, Wrensch M, Chang S, Walsh K, Myong S, Song J, Costello J

PTPS-20: The GD3 acetylation pathway as a potential therapeutic target for paediatric medulloblastoma
Mather R, Stephenson K, Donovan L, Taylor M, Vlasak R, Pilkington G, Fillmore H

NIMG-47: Pathologically confirmed viable tumor surrounds regions of progressively expanding diffusion- restricted necrosis following bevacizumab treatment
LaViolette P, Milbach N, Connelly J, Rand S, Schmainda K, Cochran E

 

2015 INTERNATIONAL TRAVEL SCHOLARSHIP AWARD WINNERS

Teddy Totimeh, MPhil, MBChB, Korle Bu Teaching Hospital, Accra, Ghana
Jayson L. Co, MD, University of Santo Tomas Hospital, Malabon City, Philippines
Esteban Jaramillo-Jiménez, MD, Instituto Neurologico de Columbia, Universidad CES, Medellin, Columbia
Srinivas Chilukuri, MD, Yashoda Hospital, Hyderabad, India
Amancio Guerrero Maldonado, MD, Mexican Institue of Social Security, Salvatierra, Mexico
Mostafa Aly Hamed Ahmed ElNaggar, PhD, Alexandria University, Alexandra, Egypt
Jie Ma, MD, PhD, Shanghai Xinhua Hospital, Shanghai, China
Ahmed Elbushra Ahmed Doomi, MD, Hamad Medical Corporation, Doha, Qatar
Muhammad Tahir, MBBS, FCPS, Jinnah Hospital, Lahore, Pakistan
Emil Makimbetov, MD, National Center of Oncology, KokDgar, Krygyzstan